当前位置: 首页 > 期刊 > 《中国民族民间医药·下半月》 > 2024年第5期
编号:1974730
童安荣主任从脾肾论治膜性肾病临证经验
http://www.100md.com 2024年6月28日 中国民族民间医药·下半月 2024年第5期
     刘梦瑶 童安荣

    【摘 要】 膜性肾病是引起肾病综合征的主要发病原因之一,临床治疗膜性肾病一般会采用在糖皮质激素药物基础上联合运用环磷酰胺的治疗方案,该方案一经实施取得了不错的疗效。然而,疾病的反复发作及药物的不良反应等仍是临床治疗的难题。童安荣主任根据多年临床经验认为膜性肾病前期以脾肾两虚为主,后期多为脾肾阳虚,水湿泛滥。治疗上应从本虚标实出发,以脾肾论治为纲,前期健脾补肾,辅助以疏肝宣肺,后期治疗以温阳为主,并注重祛湿化瘀,临床效果显著。

    【关键词】 膜性肾病;脾肾;童安荣;名医经验

    【中图分类号】R256.51 【文献标志码】 A【文章编号】1007-8517(2024)10-0086-04

    DOI:10.3969/j.issn.1007-8517.2024.10.zgmzmjyyzz202410017

    Director Tong Anrong Discussed Clinical Experience in Treating Membranous Nephropathy from Spleen and Kidney

    LIU Mengyao1 TONG Anrong2△

    1.Gansu University of Chinese Medicine,Lanzhou 730000,China;

    2.Ningxia Chinese Medicine Research Center,Yinchuan 750000,China

    Abstract:Membranous nephropathy is one of the main causes of nephrotic syndrome. In clinical treatment of membranous nephropathy,cyclophosphamide combined with glucocorticoid drugs is generally used,which has achieved good effect once implemented.However,the recurrence of the disease and the adverse reactions of drugs are still difficult problems in clinical treatment.According to many years of clinical experience,Director Tong Anrong believed that membranous nephropathy was mainly characterized by spleen and kidney deficiency in the early stage ......

您现在查看是摘要页,全文长 12941 字符